Adamu Uzairu

Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions

Saudatu Chinade Ja’afaru, Adamu Uzairu, Muhammed Sani Sallau et al. · PLoS ONE · 2024 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease

Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza et al. · Frontiers in Molecular Biosciences · 2023 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-Based Drug Design of Novel Piperazine Containing Hydrazone Derivatives as Potent Alzheimer Inhibitors: Molecular Docking and Drug Kinetics Evaluation

Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa et al. · Brain Disorders · 2022 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Molecular modelling studies of substituted indole derivatives as novel influenza a virus inhibitors

Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa et al. · Journal of Biomolecular Structure and Dynamics · 2023 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design of some potent non-toxic Autoimmune disorder inhibitors based on 2D-QSAR, CoMFA, molecular docking, and molecular dynamics investigations

Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza et al. · Intelligent Pharmacy · 2024 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17